Free Trial

Evogene (EVGN) Short Interest Ratio & Short Volume

$0.77
-0.05 (-5.96%)
(As of 03:55 PM ET)

Evogene Short Interest Data

Current Short Interest
62,400 shares
Previous Short Interest
97,800 shares
Change Vs. Previous Month
-36.20%
Dollar Volume Sold Short
$42,719.04
Short Interest Ratio
0.6 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
41,220,000 shares
Percentage of Shares Shorted
0.15%
Today's Trading Volume
103,991 shares
Average Trading Volume
150,172 shares
Today's Volume Vs. Average
69%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Evogene ?

Sign up to receive the latest short interest report for Evogene and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EVGN Short Interest Over Time

EVGN Days to Cover Over Time

EVGN Percentage of Float Shorted Over Time

Evogene Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202462,400 shares $42,719.04 -36.2%N/A0.6 $0.68
4/30/202497,800 shares $67,755.84 +40.3%N/A0.6 $0.69
4/15/202469,700 shares $47,835.11 -19.4%N/A0.4 $0.69
3/31/202486,500 shares $64,875.00 +20.8%N/A0.5 $0.75
3/15/202471,600 shares $58,712.00 -47.5%N/A0.4 $0.82
2/29/2024136,300 shares $124,196.56 +25.7%N/A0.6 $0.91
2/15/2024108,400 shares $81,137.40 -11.0%N/A0.5 $0.75
1/31/2024121,800 shares $93,177.00 -3.0%N/A0.8 $0.77
1/15/2024125,500 shares $117,719.00 -18.4%N/A0.8 $0.94
12/31/2023153,700 shares $129,108.00 -17.9%N/A1 $0.84
12/15/2023187,200 shares $131,189.76 -35.0%N/A1.3 $0.70
11/30/2023287,800 shares $187,127.56 +32.3%N/A2.3 $0.65
11/15/2023217,500 shares $143,898.00 +20.6%N/A2 $0.66
10/31/2023180,400 shares $86,429.64 -28.8%N/A1.3 $0.48
10/15/2023253,400 shares $118,616.54 -11.3%N/A1.6 $0.47
9/30/2023285,600 shares $167,504.40 +20.0%N/A1 $0.59
9/15/2023238,000 shares $159,698.00 -8.9%N/A0.7 $0.67
8/31/2023261,100 shares $194,075.63 -12.7%N/A0.7 $0.74
8/15/2023299,200 shares $238,163.20 -10.7%N/A0.8 $0.80
7/31/2023334,900 shares $354,994.00 -33.8%N/A1 $1.06
7/15/2023505,800 shares $708,120.00 -8.5%N/A1.7 $1.40
6/30/2023552,800 shares $591,496.00 +118.7%1.4%3.5 $1.07
6/15/2023252,800 shares $195,161.60 +13.0%0.6%2 $0.77
5/31/2023223,800 shares $134,324.76 -22.5%0.6%3.1 $0.60
5/15/2023288,700 shares $193,313.52 +13.4%0.7%3.9 $0.67
4/30/2023254,500 shares $149,111.55 -1.3%0.6%3.1 $0.59
4/15/2023257,900 shares $149,917.27 +2.6%0.7%2.8 $0.58
3/31/2023251,300 shares $158,319.00 +42.9%0.6%2.6 $0.63
3/15/2023175,900 shares $115,918.10 +11.2%0.4%1.6 $0.66
2/28/2023158,200 shares $120,232.00 -31.2%0.4%1.5 $0.76
2/15/2023230,000 shares $195,500.00 -7.9%0.6%2.1 $0.85
1/31/2023249,600 shares $199,655.04 +45.0%0.6%2.4 $0.80
1/15/2023172,200 shares $129,150.00 -0.9%0.4%1.9 $0.75
12/30/2022173,800 shares $121,660.00 -35.2%0.4%2 $0.70
12/15/2022268,100 shares $189,653.94 +42.6%0.7%2.9 $0.71
11/30/2022188,000 shares $117,970.00 -5.8%0.5%2.5 $0.63
11/15/2022199,600 shares $143,712.00 -19.4%0.5%2.5 $0.72
10/31/2022247,500 shares $180,675.00 +23.9%0.6%2.6 $0.73
10/15/2022199,700 shares $141,767.03 +3.2%0.5%1.9 $0.71
9/30/2022193,500 shares $160,605.00 -9.8%0.5%1.8 $0.83
Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
9/15/2022214,400 shares $218,688.00 -1.1%0.6%1.9 $1.02
8/31/2022216,700 shares $225,368.00 +22.9%0.6%1.8 $1.04
8/15/2022176,300 shares $205,883.14 -22.7%0.5%1.4 $1.17
7/31/2022228,100 shares $187,042.00 -14.2%0.6%1.7 $0.82
7/15/2022265,700 shares $215,217.00 -21.4%0.7%1.9 $0.81
6/30/2022338,000 shares $260,260.00 -11.8%0.9%2.2 $0.77
6/15/2022383,300 shares $295,141.00 -29.4%1.0%2.3 $0.77
5/31/2022542,900 shares $514,397.75 -5.0%1.4%2.2 $0.95
5/15/2022571,400 shares $511,345.86 -24.8%1.5%2 $0.89
4/30/2022759,800 shares $805,388.00 +4.7%2.0%2.4 $1.06
4/15/2022725,900 shares $863,821.00 -5.4%1.9%2.2 $1.19
3/31/2022767,700 shares $998,010.00 -7.3%N/A2.2 $1.30
3/15/2022828,000 shares $968,760.00 +33.2%2.1%2.1 $1.17
2/28/2022621,700 shares $808,210.00 -9.5%1.6%1.9 $1.30
2/15/2022687,200 shares $872,744.00 -10.2%1.8%2.1 $1.27
1/31/2022765,000 shares $1.06 million +3.5%2.0%2.2 $1.39
1/15/2022739,000 shares $1.16 million +47.4%N/A2.2 $1.57
12/31/2021501,300 shares $822,132.00 -16.8%1.3%1.6 $1.64
12/15/2021602,500 shares $1.10 million +20.9%1.6%2 $1.82
11/30/2021498,400 shares $991,816.00 +5.3%1.3%1.7 $1.99
11/15/2021473,500 shares $1.16 million -14.1%1.2%1.3 $2.45
10/29/2021551,100 shares $1.44 million -33.2%1.5%1.7 $2.61
10/15/2021825,300 shares $2.21 million +9.9%2.2%2.4 $2.68
9/30/2021751,300 shares $1.98 million +1.2%2.0%2.2 $2.64
9/15/2021742,200 shares $2.03 million +26.3%2.0%2.1 $2.74
8/31/2021587,600 shares $1.76 million -22.5%1.5%1.6 $3.00
8/13/2021758,600 shares $2.26 million +17.1%2.0%2.1 $2.98
7/30/2021647,900 shares $1.85 million -6.8%1.7%1.7 $2.86
7/15/2021694,900 shares $2.14 million -11.6%1.8%1.7 $3.08
6/30/2021786,200 shares $2.69 million -4.0%2.1%1.7 $3.42
6/15/2021818,800 shares $2.97 million -16.6%2.2%1.5 $3.63
5/28/2021981,400 shares $3.42 million -16.8%2.6%1.6 $3.48
5/14/20211,180,000 shares $3.89 million +30.0%3.1%1.3 $3.30
4/30/2021908,000 shares $4.11 million -11.0%2.4%0.8 $4.53
4/15/20211,020,000 shares $4.72 million +18.3%N/A0 $4.63
3/31/2021862,000 shares $4.01 million +0.9%2.3%0.5 $4.65
3/15/2021854,100 shares $4.77 million -38.6%2.6%0.4 $5.59
2/26/20211,390,000 shares $8.44 million +0.7%4.6%0.7 $6.07
2/12/20211,380,000 shares $13.72 million -16.9%4.6%0.7 $9.94
1/29/20211,660,000 shares $10.54 million +4.4%5.8%0.9 $6.35
1/15/20211,590,000 shares $9.46 million +62.2%5.3%1 $5.95
12/31/2020980,100 shares $4.80 million +68.6%3.6%0.7 $4.90
12/15/2020581,200 shares $2.30 million +56.3%2.1%0.5 $3.96
11/30/2020371,900 shares $1.10 million +17.8%1.4%0.3 $2.96
11/15/2020315,800 shares $802,132.00 +16.8%1.2%0.3 $2.54
10/30/2020270,400 shares $803,088.00 -27.9%1.2%0.3 $2.97
10/15/2020374,900 shares $1.42 million -47.0%1.6%0.4 $3.80
9/30/2020706,900 shares $2.80 million +1,022.1%3.8%0.9 $3.96
9/15/202063,000 shares $168,210.00 -37.5%0.3%0.1 $2.67
8/31/2020100,800 shares $208,656.00 +90.9%0.5%0.3 $2.07
Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
8/14/202052,800 shares $73,920.00 -2.4%0.3%0.3 $1.40
7/31/202054,100 shares $56,285.64 -5.6%0.3%0.4 $1.04
7/15/202057,300 shares $55,581.00 +62.3%0.3%0.5 $0.97
6/30/202035,300 shares $35,289.41 -18.9%0.2%0.4 $1.00
6/15/202043,500 shares $45,240.00 -24.5%0.2%0.6 $1.04
5/29/202057,600 shares $60,480.00 +11.0%0.3%1.6 $1.05
5/15/202051,900 shares $52,938.00 -29.7%0.3%2.6 $1.02
4/30/202073,800 shares $82,929.06 +64.7%0.4%3.4 $1.12
4/15/202044,800 shares $47,040.00 +11.4%N/A2.2 $1.05
3/31/202040,200 shares $42,210.00 -61.6%N/A2 $1.05
3/13/2020104,800 shares $115,280.00 +147.8%N/A3.2 $1.10
2/28/202042,300 shares $38,493.00 +94.9%N/A2 $0.91
2/14/202021,700 shares $21,917.00 -32.6%0.1%1.2 $1.01
1/31/202032,200 shares $45,080.00 +7.7%0.2%2.2 $1.40
1/15/202029,900 shares $42,458.00 -26.7%0.1%3 $1.42
12/31/201940,800 shares $69,360.00 +229.0%0.2%4.6 $1.70

EVGN Short Interest - Frequently Asked Questions

What is Evogene's current short interest?

Short interest is the volume of Evogene shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 62,400 shares of EVGN short. Learn More on Evogene's current short interest.

What is a good short interest ratio for Evogene?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVGN shares currently have a short interest ratio of 1.0. Learn More on Evogene's short interest ratio.

Is Evogene's short interest increasing or decreasing?

Evogene saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 62,400 shares, a decline of 36.2% from the previous total of 97,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Evogene's short interest compare to its competitors?

Here is how the short interest of companies compare to Evogene: ImmunoPrecise Antibodies Ltd. (0.93%), Bolt Biotherapeutics, Inc. (8.82%), Singular Genomics Systems, Inc. (0.98%), T2 Biosystems, Inc. (22.49%), JanOne Inc. (2.92%), Viracta Therapeutics, Inc. (2.42%), SeaStar Medical Holding Co. (2.98%), NeuroOne Medical Technologies Co. (1.11%), Spectral AI, Inc. (5.48%), Femasys Inc. (4.06%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Evogene stock?

Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. EVGN shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evogene?

A short squeeze for Evogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further.

How often is Evogene's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:EVGN) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners